Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Gothenburg Breast Screening Trial.

Nils Bjurstam1, Lena Björneld, Jane Warwick

  • 1Department of Radiology, Center for Breast Imaging, University Hospital of North Norway, Tromsø, Norway. nils.bjurstam@unn.no

Cancer
|May 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pelvic MRI in Endometrial Cancer Staging: A Retrospective Evaluation of the Impact of FIGO 2023.

Radiology·2026
Same author

Diagnostic performance of bpMRI versus mpMRI and AI-assisted bpMRI in prostate cancer detection: a multi-reader study.

La Radiologia medica·2026
Same author

Response to: Adjusting for non-compliance and contamination with a more plausible assumption.

Journal of medical screening·2026
Same author

Generating synthetic CEM from low-energy images using deep learning: A future without contrast media? A proof-of-concept study.

European radiology experimental·2026
Same author

AI decision support for increasing prostate biopsy efficiency: a retrospective multicentre, multiscanner study.

European radiology·2026
Same author

Personalised medicine through AI-enhanced integration of diagnostic imaging and radiation therapy.

European radiology experimental·2025

Mammographic screening for breast carcinoma shows a reduction in mortality, particularly in certain age groups. Further research into age-specific effects is recommended for women under 50.

Area of Science:

  • Oncology
  • Public Health
  • Radiology

Background:

  • Mammographic screening for breast carcinoma is established, but age-specific effectiveness remains debated.
  • Uncertainty exists regarding the precise impact of screening on mortality across different age demographics.

Purpose of the Study:

  • To evaluate the overall and age-specific effects of mammographic screening on breast carcinoma mortality.
  • To analyze mortality data using multiple evaluation models and registers for robust assessment.

Main Methods:

  • A randomized controlled trial involving 51,611 women aged 39-59 in Gothenburg, Sweden, with an 18-month screening interval.
  • Mortality analysis using Poisson regression, comparing invited women to a control group, with follow-up until December 1996.
  • Three evaluation models (EPC, SCB evaluation, SCB follow-up) were employed to assess breast carcinoma mortality.

Related Experiment Videos

Main Results:

  • A 21% nonsignificant reduction (RR 0.79) and a borderline significant 23% reduction (RR 0.77) in breast carcinoma mortality were observed.
  • Greater mortality reductions were seen in women aged 39-44, 45-49, and 55-59, but not in the 50-54 age group.
  • Screening effects on lymph node-positive disease incidence paralleled mortality effects; incidence was similar post-trial, indicating no significant long-term impact on disease occurrence.

Conclusions:

  • Results support a 20-30% reduction in breast carcinoma mortality with mammographic screening invitation.
  • The perceived lower effectiveness in women under 50 may be an oversimplification; age-specific effects require further investigation.
  • Targeted research on age-specific effects of mammography screening is crucial for refining screening guidelines.